4.4 Article

REPLATINUM Phase III randomized study: RRx-001+platinum doublet versus platinum doublet in third-line small cell lung cancer

Related references

Note: Only part of the references are listed.
Meeting Abstract Oncology

Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.

Hyun Cheol Chung et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

Cancer Statistics, 2016

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Oncology

Cancer Statistics, 2009

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2009)

Review Pharmacology & Pharmacy

Clinical perspectives on platinum resistance

G Giaccone

DRUGS (2000)